You are here

The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.


ASCO 2020 x

In June, BCRF researcher Dr. Lori Pierce began her year as president of the American Society of Clinical Oncology (ASCO), one of the most prominent professional organizations for oncology professionals and physicians in the world.

Designed graphic with Nancy LIn's headshot and call to action to click to watch the video interview

As many as half of patients diagnosed with metastatic HER2-positive breast cancer will see their cancer spread to their brain. Though brain metastases are rare, they are exceedingly difficult to treat, so breast cancer patients with “brain mets” experience poor outcomes.

an illustration of a breast tumor cell in orange against a black background

Breast cancer metastasis is a complex process—and the leading cause of breast cancer deaths. At this year’s American Society of Clinical Oncology (ASCO) virtual annual meeting, researchers presented several studies that addressed the challenges of treating metastatic breast cancer.

chemotherapy IV against blue background

Treatment optimization–balancing efficacy with toxicity–remains a clinical challenge in early-stage breast cancer and was a major focus of clinical trials featured at this year’s virtual annual meeting of the American Society of Clinical Oncology (ASCO). Below are key highlights:

Portrait of the late Dr. Bernard Fisher

The Breast Cancer Research Foundation endowed a new clinical science symposium at this year’s American Society of Clinical Oncology (ASCO) annual meeting to honor the late Dr. Bernard Fisher, a pioneering breast cancer surgeon and researcher.

Dr. Lori J. Pierce presents at ASCO's 2018 annual meeting.

The American Society of Clinical Oncology’s (ASCO) annual conference is the largest meeting in the world focused on clinical oncology—typically attracting more than 35,000 attendees, including clinical and laboratory scientists and trainees, patient advocates, and representatives from the pharmac